Trending Now
  • WHY LITIGATION FUNDERS WIN OR LOSE OPPORTUNITIES BEFORE CASE REVIEW BEGINS

High Court confirms use of public examination powers to investigate potential class actions

High Court confirms use of public examination powers to investigate potential class actions

The High Court has ruled in favour of shareholders in Walton & Anor v ACN 004 410 833 Ltd (formerly Arrium Limited) (in liq) & Ors. In a 3:2 decision, the majority permitted former shareholders of Arrium Ltd to examine the insolvent company’s officers under s 596A of the Corporations Act 2001 (‘CA’) for the purpose of potentially bringing a class action against the company’s managers. The Road Ahead The High Court (3:2) decision is positive news for shareholder class actions as it confirms that “eligible applicants” can publicly examine corporate officers about a corporation’s affairs, to test the merits of a potential class action against the company. This is even if a liquidator does not intend to investigate or pursue claims against the officers of the company. The approach adopted by the majority is a welcome step forward for corporate accountability in the midst of many attempts by the legislature to constrict the Australian class action landscape. Procedural history The applicants were shareholders in a former mining company, Arrium Ltd (‘Arrium’). The applicants bought shares in Arrium during a capital raising in 2014. Shortly thereafter, Arrium announced an impairment to the value of its business of over $1billion. Arrium was then placed into administration, and then finally liquidation. Under s 596A CA, the Court is to summon a person for examination about a corporation’s ‘examinable affairs’ if an eligible applicant seeks the order, and the court is satisfied that the person subject to the order was an officer or liquidator of the corporation during the prescribed period. With authorisation from ASIC, the applicants sought an order from the Supreme Court of New South Wales summoning a former director of Arrium for public examination. The applicants sought the order,  as they believed that they may have claims against the former directors and auditors of Arrium arising out of the capital raising and the company’s published financial results for the same period. The goal of the examination was to investigate whether pursuing these claims as a class action with other shareholders was viable. The Supreme Court of New South Wales initially granted the order.  However, the Court of Appeal overturned the decision to allow the examination on the basis that it was an abuse of process, as the examination did not benefit Arrium, its creditors, or its contributories. The issue to be determined by the High Court was whether the applicant’s purpose for seeking the order was an abuse of process. This involved considering whether the purpose of the application was consistent with the purpose of s 596A CA. Was the Proposed Examination an abuse of process? The majority (Justices Edelman, Steward and Gageler) allowed the appeal, finding that the application was not an abuse of process. The purpose for the application was held to be within the scope of s 596A CA. In coming to this conclusion, the court considered section 596A CA to ascertain its purpose, which involved lengthy consideration of the preceding iterations of the statutory scheme for public examinations. The High Court acknowledged that earlier laws insisted on public examinations being for the benefit of the company or its creditors, or for bringing criminal or regulatory proceedings in connection with the company. However, the High Court concluded that these requirements did not apply to bringing an application under s 596A CA because s 596A CA has no direct analogy with any former provision in the earlier companies’ legislation. Instead, the court held that s 596A has much broader requirements than the former laws on this issue. This is because: 1.     section 596A CA is drafted differently, and applications under it require less supporting evidence than earlier companies’ legislation and other sections within the same part of the Corporations Act 2001; 2.      section 596A CA was intentionally drafted to have a broad application; 3.     section 596A was enacted in the public interest to facilitate the administration or enforcement of the law concerning a corporation and its officers in public dealings. Therefore, an application under this section will not be an abuse of process if it promotes compliance with the law. On this basis, the High Court concluded that using a compulsory examination to test the merits of a potential class action for corporate misconduct coincides with the purpose of s 596A CA. The fact that the proposed class action would not benefit all of Arrium’s shareholders did not jeopardise the validity of the application, because s 596A CA is directed to enforcing the law, rather than benefitting the company in administration. The judgment is available here: Walton v ACN 004 410 833 (formerly Arrium Ltd) (in liq) [2022] HCA 3, 16 February 2022. About the Authors Lillian Rizio specialises in managing large scale complex litigation, particularly with claims involving multiple parties. Lillian’s emphasis is on corporate disputes, class actions, professional negligence and insurance, across most Australian jurisdictions. Lillian also has extensive experience advising clients in relation to right to information matters, in both federal and state jurisdictions Julia Hegarty is a law clerk in the Dispute Resolution and Litigation team at Piper Alderman in Brisbane. She is currently studying a Bachelor of Commerce/Laws (Hons) at the University of Queensland. Julia has an interest in externally funded litigation and shareholder class actions. For queries or comments in relation to this article please contact Kat Gieras, Litigation Group Project Coordinator | T: +61 7 3220 7765 | E:  kgieras@piperalderman.com.au

Commercial

View All

Omni Bridgeway Unveils Pro Bono Recycling Fund for Migrant Domestic Workers and Backs iyO in High-Profile IP Suit Against OpenAI, Altman, and Jony Ive

By John Freund |

Omni Bridgeway has moved on two distinct fronts in recent weeks, pairing a first-of-its-kind pro bono disbursement facility for migrant domestic workers in Asia with a high-profile commercial commitment to fund iyO Inc.'s intellectual property and trade secret suit against OpenAI, Sam Altman, and Sir Jony Ive. Taken together, the announcements showcase the breadth of the ASX-listed funder's pipeline — from access-to-justice initiatives at one end to flagship technology disputes at the other.

According to a joint Omni Bridgeway announcement, the funder has partnered with Hong Kong–based NGO Justice Without Borders to launch a "recycling" disbursement fund that covers court fees, expert reports, translation services, and court-ordered security for costs deposits in cross-border employment claims brought by migrant domestic workers across Hong Kong, Singapore, Indonesia, and other jurisdictions where JWB operates. The structure is designed so that recoveries are routed back into the facility, allowing each dollar of capital to support multiple claims over time. JWB executive director Celine Chan framed the initiative around the principle that "justice should not stop at a border or depend on ability to afford court fees," while Omni Bridgeway's Mitchell Dearness said the facility "fills a critical gap by covering costs that pro bono representation alone cannot address." The fund's headline commitment was not disclosed.

On the commercial side, according to a PR Newswire announcement from iyO, Omni Bridgeway is now backing iyO's federal litigation against OpenAI, Sam Altman, Jony Ive, io Products Inc., and former io co-founder Tang Yew Tan in the U.S. District Court for the Northern District of California (Case No. 25-cv-04861-TLT). iyO, a Google X spinout developing screenless, voice-controlled ear-worn devices, alleges trademark infringement of its federally registered "IYO" mark and trade secret misappropriation under both the California Uniform Trade Secrets Act and the federal Defend Trade Secrets Act over OpenAI's use of the "io" brand and the conduct of the io team after its acquisition. U.S. District Judge Trina L. Thompson granted a preliminary injunction in April 2026 finding iyO "likely to succeed on the merits of its trademark claim," after the Ninth Circuit affirmed an earlier temporary restraining order in December 2025. Trade-secret claims were added in March 2026.

For Omni Bridgeway, the two announcements land at a moment when public-market funders are working to demonstrate both portfolio breadth and capital efficiency to investors and clients. The recycling fund extends the firm's brand into access-to-justice territory long associated with NGOs and pro bono law firms, while the iyO matter places it directly into the most closely watched generative-AI dispute on the docket — a posture that allows Omni Bridgeway to argue, simultaneously, that litigation finance can democratize cross-border employment claims and underwrite the bet-the-product cases that define the next era of technology competition.

Litigation Capital Management Extends Northleaf Covenant Waiver to June 30, Flags Material Case Write-Downs

By John Freund |

AIM-listed litigation funder Litigation Capital Management has secured a one-month extension of its debt covenant waiver from senior lender Northleaf to June 30, 2026, while disclosing negative developments in two case investments and warning that material write-downs will be reflected in upcoming financial statements.

According to a Litigation Capital Management regulatory announcement, the waiver continues on existing terms, with interest on the Northleaf facility remaining elevated by 2.00 percentage points per annum and no additional waiver fee charged. The two affected investments account for approximately A$9 million in invested capital between them; LCM did not identify the specific funded matters but said the negative outcomes will require material write-downs in its forthcoming results.

The funder added that the strategic review initiated in September 2025 remains ongoing and that the waiver extension reflects Northleaf's "ongoing support while LCM works towards a long-term resolution of its capital position." LCM's London-listed shares fell roughly 13% on the news.

The update is the latest in a sequence of capital-stack adjustments and adverse case developments that have weighed on LCM since late 2025, and reinforces the operating reality that publicly traded funders face: portfolio-level returns can be overwhelmed at the equity line by a small number of high-conviction matters that resolve adversely. With the waiver now tied to a June 30 deadline, the next four weeks are likely to determine both the contours of the strategic review and the terms of any new lender arrangement.

Trade Press Revisits How Litigation Funding Became Entangled in U.S. Meat Industry Antitrust Battles

By John Freund |

The U.S. meat industry trade press has stepped back to examine how third-party litigation funding became central to the multi-year wave of antitrust cases against Tyson Foods, Pilgrim's Pride, and other major packers, with Burford Capital's funding of Sysco's protein price-fixing claims serving as the defining storyline.

As reported by Meatingplace, Sysco and Burford entered a Capital Provision Agreement under which the funder invested approximately $140 million from 2019 onward to back Sysco's direct-purchaser antitrust cases in beef, pork, chicken, and turkey. The relationship later fractured when Sysco moved to settle several matters at values Burford regarded as far below their merit-driven worth, leading to arbitration, the assignment of Sysco's remaining claims to Burford-affiliated vehicle Carina Ventures, and a high-profile Seventh Circuit ruling earlier this year that allowed Burford to challenge a $50 million Sysco settlement in the broiler chicken docket.

The feature traces how the dispute reshaped procurement-side antitrust strategy across the protein sector, with Sysco at one point accusing Burford in court filings of turning the federal docket into a "casino" in which the funder could veto rational settlement decisions made by the underlying claimant.

For litigation funders, the retrospective is notable less for new disclosures than for the audience it reaches — a trade publication whose readership is the corporate procurement and operations community now thinking about whether to bring, settle, or finance their own antitrust recoveries against the same packer defendants in the years ahead.